Zobrazeno 1 - 3
of 3
pro vyhledávání: '"JM Montoya Egea"'
Autor:
CN García Matillas, AM Chica Marchal, JM Montoya Egea, IM Fernandez Martinez, JM Martinez Marcos, J Fernandez Vela
Publikováno v:
Section 3: Production and compounding.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56851c0fc086023ba1b5d113eb5b01d9
https://doi.org/10.1136/ejhpharm-2022-eahp.30
https://doi.org/10.1136/ejhpharm-2022-eahp.30
Autor:
JM Montoya Egea, CN García Matillas, A Lloret Llorca, C Juez Santamaría, S Nuñez Bracamonte, MH García Lagunar, I Fernández Martínez, E Conesa Nicolás
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance The new direct acting antivirals (DAAs), indicated in chronic hepatitis C (HCV), show a sustained virological response at 12 weeks (SVR12) >90% in clinical trials, with worse results in patients with genotype 3. Aim and obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0625cad493619f8009e76ae7e666e2c4
https://doi.org/10.1136/ejhpharm-2020-eahpconf.102
https://doi.org/10.1136/ejhpharm-2020-eahpconf.102
Autor:
MC González Pérez-Crespo, JM Montoya Egea, E Conesa Nicolás, CN García Matillas, A Lloret Llorca, I Fernández Martínez, C Juez Santamaría, S Nuñez Bracamonte
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Therapeutic equivalents are drugs with a different chemical structure but with similar therapeutic and adverse effect profiles when equivalent doses are administered. Aim and objectives To analyse the pharmacotherapeutic int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45d13645fd9912b501575abce8d426bb
https://doi.org/10.1136/ejhpharm-2020-eahpconf.253
https://doi.org/10.1136/ejhpharm-2020-eahpconf.253